newsfilter
← Latest News
Business Wire·

Acorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&A

April 4, 2023 at 1pm ET, 10am PT Participants Invited to Submit Questions to the CEO Acorda Therapeutics, Inc. (NASDAQ:ACOR) will hold a virtual, video Q&A with its CEO, Ron Cohen, M.D., on Tuesday, April 4 at